United States News Todas as matérias

Sealed Air (NYSE:SEE) today announced that it has received all required regulatory approvals for its pending acquisition by funds affiliated with Clayton, Dubilier & Rice (CD&R).

Talphera (NASDAQ:TLPH) today reported financial results for the fourth quarter and full year ended December 31, 2025, detailing the fiscal costs of its ongoing transition into a specialized developer of hospital-based therapies.

Envoy Medical (NASDAQ:COCH) today reported its financial and operational results for the fiscal year ended December 31, 2025, marking a year of significant regulatory progress and balance sheet restructuring.

Avalo Therapeutics (NASDAQ:AVTX), a clinical-stage biotechnology company focused on developing interleukin-1β (IL-1β)-targeting therapies for immune-mediated inflammatory diseases, reported its financial results for the full year ended December 31, 2025.

Cabaletta Bio (NASDAQ:CABA) today reported financial results for the fourth quarter and full year ended December 31, 2025, providing a definitive timeline for the regulatory submission of its lead product candidate.

Xilio Therapeutics (NASDAQ:XLO) today reported its financial results for the fourth quarter and full year ended December 31, 2025, detailing a year of disciplined platform validation and pipeline expansion.

Ondas Holdings (NASDAQ:ONDS) today reported a landmark financial performance for the fourth quarter and full year ended December 31, 2025, marking its transition from an early-stage innovator to a high-scale industrial technology leader.

Cheer Holding (NASDAQ:CHR) officially filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, revealing a year of financial consolidation and strategic preparation.

Arbutus Biopharma (NASDAQ:ABUS) today reported a landmark set of financial and clinical results for the fourth quarter and full year ended December 31, 2025.

BioLineRx (NASDAQ:BLRX) today announced its audited financial results for the full year ended December 31, 2025, detailing a period of significant fiscal discipline and pipeline maturation.

Bausch + Lomb (NYSE:BLCO) today unveiled positive topline results from its pivotal 24-month U.S. clinical trial of the ELIOS System, an innovative, implant-free procedure designed to treat elevated intraocular pressure (IOP) in patients with open-angle glaucoma.

Viatris (NASDAQ:VTRS) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Effexor® SR (venlafaxine hydrochloride) sustained-release capsules for the treatment of adults with generalized anxiety disorder (GAD).

Jacobs (NYSE:J) announced today the completion of its acquisition of the remaining equity interest in PA Consulting, a leading innovation and transformation consultancy.

Lithium Argentina (NYSE:LAR) today announced its financial and operational results for the fourth quarter and full year ended December 31, 2025, marking a year of significant operational maturity.

Finnair has reached a definitive agreement with Embraer (NYSE:EMBJ) to acquire up to 46 E195-E2 aircraft, marking one of the largest single investments in the Finnish flag carrier’s 102-year history.

Grab Holdings (NASDAQ:GRAB) today announced a definitive agreement to acquire the Taiwanese operations of foodpanda from Delivery Hero for $600 million in cash.

McEwen (NYSE:MUX) today announced a significant milestone in its strategy to double corporate production, releasing a new Mineral Resource Estimate (MRE) for its 100%-owned Tartan Mine Project near Flin Flon, Manitoba.

Ennis (NYSE:EBF), a premier manufacturer of business forms and essential printed products, announced today that its Board of Directors has declared a quarterly cash dividend of $0.25 per share on the company’s common stock.

Gamehaus (NASDAQ:GMHS) today announced its unaudited financial results for the second quarter of fiscal 2026, ended December 31, 2025, revealing a quarter defined by significantly improved bottom-line efficiency.

Nexra, the dedicated Operations & Maintenance (O&M) division of Cadeler (NYSE:CDLR), confirmed today the signing of an additional firm contract for a maintenance campaign in Taiwan scheduled for completion in 2026.

BioArctic (NASDAQ:B) and its partner Eisai presented significant new data at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) in Copenhagen, highlighted by the first large-scale look at real-world long-term persistence for the Alzheimer's treatment lecanemab.

HUTCHMED (NASDAQ:HCM) announced the initiation of a registrational Phase III clinical trial for HMPL-760, an investigational non-covalent Bruton’s tyrosine kinase (BTK) inhibitor.

Evotec (NASDAQ:EVO) announced today that its Seattle-based subsidiary, Just - Evotec Biologics, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to optimize the manufacturing of medical countermeasures against life-threatening filoviruses.

NextEra Energy (NYSE:NEE), the largest energy infrastructure builder in the United States, confirmed today that President Donald J. Trump has approved the development of up to 10 gigawatts (GW) of natural gas-powered generation in Texas and Pennsylvania.